West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Is the P/B ratio high or low?

The P/B ratio of 8.49 is in line with its 5-year average of 9.34, near the low end of its 5-year range (5.23–17.45).

33.75% above its 12-month average of 6.35.

WST PB Ratio

WST PB Ratio Chart

8.49
+42.45% 1Y
WST PB Ratio

WST Average PB Ratio Chart

WST PB Ratio

WST Current vs Average PB Ratio Chart

WST PB Ratio Metrics

PB RATIO

8.49

PB RATIO AVG TTM

6.35

PB RATIO AVG 3Y

7.99

PB RATIO AVG 5Y

8.81

PB RATIO AVG 10Y

8.39

PB RATIO AVG 15Y

6.70

PB RATIO AVG 20Y

5.54

CURRENT VS TTM AVG

+33.75%

CURRENT VS 3Y AVG

+6.25%

CURRENT VS 5Y AVG

-3.66%

CURRENT VS 10Y AVG

+1.18%

CURRENT VS 15Y AVG

+26.76%

CURRENT VS 20Y AVG

+53.15%

WST Competitors' PB Ratio

NAMEMARKET CAPPB RATIOTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B8.496.357.998.81
Waters Corporation (WAT)vs ›$24.41B2.017.9013.6031.52
Mettler-Toledo International Inc. (MTD)vs ›$25.54BN/A1966.63623.56375.27
Quest Diagnostics Incorporated (DGX)vs ›$23.23B3.192.912.662.69
BioNTech SE (BNTX)vs ›$23.07B1.071.131.152.31
United Therapeutics Corporation (UTHR)vs ›$23.03B4.343.292.702.61
Moderna, Inc. (MRNA)vs ›$26.69B3.591.692.074.75
Incyte Corporation (INCY)vs ›$22.73B4.244.023.593.94
DexCom, Inc. (DXCM)vs ›$27.07B9.3410.6716.1018.81
Labcorp Holdings Inc. (LH)vs ›$22.26B2.582.602.412.24

P/B vs. its own history

At 8.49, P/B is richer than usual, sitting higher than 79% of its 20-year history.

20-year low

1.90

median

5.05

20-year high

17.45

cheaperricher

Book Value Analysis

P/B Ratio

8.49

Market Price / Book Value per Share

PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The P/B ratio for WST stock is 8.49.
Is West Pharmaceutical Services, Inc.'s P/B ratio high or low?
The P/B ratio of 8.49 is in line with its 5-year average of 9.34, near the low end of its 5-year range (5.23–17.45).
What is the TTM average P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average P/B ratio for WST stock is 6.35.
What is the 3Y average P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average P/B ratio for WST stock is 7.99.
What is the 5Y average P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average P/B ratio for WST stock is 8.81.
What is the 10Y average P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average P/B ratio for WST stock is 8.39.
What is the 15Y average P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average P/B ratio for WST stock is 6.70.
What is the 20Y average P/B ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average P/B ratio for WST stock is 5.54.

WST PB Ratio History

DATEPB RATIO
2026-06-268.49
2026-06-258.39
2026-06-248.24
2026-06-238.14
2026-06-227.98
2026-06-187.94
2026-06-177.83
2026-06-167.98
2026-06-158.02
2026-06-127.96
2026-06-118.00
2026-06-108.01
2026-06-098.10
2026-06-087.74
2026-06-057.61
2026-06-047.68
2026-06-037.66
2026-06-027.56
2026-06-017.66
2026-05-297.82
2026-05-287.79
2026-05-277.57
2026-05-267.65
2026-05-227.66
2026-05-217.65
2026-05-207.40
2026-05-197.36
2026-05-187.37
2026-05-157.33
2026-05-147.27
2026-05-137.32
2026-05-127.56
2026-05-117.80
2026-05-087.89
2026-05-077.80
2026-05-067.57
2026-05-057.50
2026-05-047.27
2026-05-017.28
2026-04-307.20
2026-04-297.15
2026-04-287.07
2026-04-277.32
2026-04-247.41
2026-04-237.50
2026-04-226.28
2026-04-216.29
2026-04-206.36
2026-04-176.27
2026-04-166.18
2026-04-156.10
2026-04-146.13
2026-04-135.95
2026-04-105.87
2026-04-095.92
2026-04-086.09
2026-04-075.94
2026-04-065.88
2026-04-025.83
2026-04-015.79
2026-03-315.74
2026-03-305.61
2026-03-275.57
2026-03-265.68
2026-03-255.65
2026-03-245.61
2026-03-235.53
2026-03-205.43
2026-03-195.50
2026-03-185.47
2026-03-175.48
2026-03-165.50
2026-03-135.39
2026-03-125.29
2026-03-115.45
2026-03-105.35
2026-03-095.68
2026-03-065.63
2026-03-055.59
2026-03-045.70
2026-03-035.75
2026-03-025.75
2026-02-275.82
2026-02-265.70
2026-02-255.67
2026-02-245.62
2026-02-235.59
2026-02-205.52
2026-02-195.58
2026-02-185.68
2026-02-175.57
2026-02-135.97
2026-02-125.80
2026-02-115.86
2026-02-105.80
2026-02-095.93
2026-02-065.93
2026-02-055.52
2026-02-045.65
2026-02-035.50
2026-02-025.66
2026-01-305.51
2026-01-295.54
2026-01-285.62
2026-01-275.73
2026-01-265.75
2026-01-235.64
2026-01-225.90
2026-01-216.08
2026-01-205.97
2026-01-166.19
2026-01-156.66
2026-01-146.55
2026-01-136.48
2026-01-126.50
2026-01-096.56
2026-01-086.56
2026-01-076.63
2026-01-066.69
2026-01-056.65
2026-01-026.59
2025-12-316.56
2025-12-306.60
2025-12-296.57
2025-12-266.54
2025-12-246.59
2025-12-236.61
2025-12-226.55
2025-12-196.49
2025-12-186.40
2025-12-176.41
2025-12-166.35
2025-12-156.48
2025-12-126.37
2025-12-116.49
2025-12-106.36
2025-12-096.34
2025-12-086.41
2025-12-056.68
2025-12-046.71
2025-12-036.77
2025-12-026.50
2025-12-016.53
2025-11-286.61
2025-11-266.60
2025-11-256.69
2025-11-246.53
2025-11-216.46
2025-11-206.14
2025-11-196.14
2025-11-186.20
2025-11-176.25
2025-11-146.23
2025-11-136.35
2025-11-126.52
2025-11-116.61
2025-11-106.56
2025-11-076.46
2025-11-066.56
2025-11-056.76
2025-11-046.84
2025-11-036.67
2025-10-316.72
2025-10-306.64
2025-10-296.79
2025-10-286.75
2025-10-276.84
2025-10-247.09
2025-10-237.32
2025-10-226.88
2025-10-216.94
2025-10-206.83
2025-10-176.73
2025-10-166.64
2025-10-156.54
2025-10-146.49
2025-10-136.52
2025-10-106.51
2025-10-096.55
2025-10-086.66
2025-10-076.61
2025-10-066.66
2025-10-036.77
2025-10-026.79
2025-10-016.75
2025-09-306.52
2025-09-296.47
2025-09-266.50
2025-09-256.32
2025-09-246.46
2025-09-236.23
2025-09-226.27
2025-09-196.33
2025-09-186.34
2025-09-176.38
2025-09-166.42
2025-09-156.40
2025-09-126.30
2025-09-116.56
2025-09-106.34
2025-09-096.26
2025-09-086.29
2025-09-056.23
2025-09-046.15
2025-09-036.19
2025-09-026.06
2025-08-296.14
2025-08-286.10
2025-08-276.11
2025-08-266.08
2025-08-256.14
2025-08-226.16
2025-08-216.03
2025-08-206.12
2025-08-196.14
2025-08-186.04
2025-08-156.12
2025-08-146.12
2025-08-136.12
2025-08-125.96
2025-08-115.97
2025-08-085.99
2025-08-075.98
2025-08-065.90
2025-08-055.94
2025-08-045.92
2025-08-015.95
2025-07-315.95
2025-07-306.19
2025-07-296.29
2025-07-286.41
2025-07-256.55
2025-07-246.94
2025-07-236.18
2025-07-225.96
2025-07-215.72
2025-07-185.74
2025-07-176.03
2025-07-166.10
2025-07-156.01
2025-07-146.11
2025-07-116.18
2025-07-106.24
2025-07-096.15
2025-07-086.00
2025-07-076.03
2025-07-036.05
2025-07-026.02
2025-07-016.05
2025-06-305.95
2025-06-275.95
2025-06-265.96
2025-06-256.01
2025-06-246.06
2025-06-235.90
2025-06-205.87
2025-06-185.93
2025-06-175.93
2025-06-166.10
2025-06-136.04

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green